TABLE 1. GLOBAL NANOMEDICINE MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 2. GLOBAL NANOMEDICINE MARKET FOR VACCINES APPLICATION, BY REGION, 2016-2023 ($MILLION)
TABLE 3. GLOBAL NANOMEDICINE MARKET FOR REGENERATIVE MEDICINE APPLICATION, BY REGION, 2016-2023 ($MILLION)
TABLE 4. GLOBAL NANOMEDICINE MARKET FOR DIAGNOSTIC IMAGING APPLICATION, BY REGION, 2016-2023 ($MILLION)
TABLE 5. GLOBAL NANOMEDICINE MARKET FOR DRUG DELIVERY APPLICATION, BY REGION, 2016-2023 ($MILLION)
TABLE 6. GLOBAL NANOMEDICINE MARKET FOR IMPLANTS APPLICATION, BY REGION, 2016-2023 ($MILLION)
TABLE 7. GLOBAL NANOMEDICINE MARKET FOR OTHERS APPLICATION, BY REGION, 2016-2023 ($MILLION)
TABLE 8. GLOBAL NANOMEDICINE MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 9. GLOBAL NANOMEDICINE MARKET FOR ONCOLOGICAL DISEASES INDICATION, BY REGION, 2016-2023 ($MILLION)
TABLE 10. GLOBAL NANOMEDICINE MARKET FOR INFECTIOUS DISEASES INDICATION, BY REGION, 2016-2023 ($MILLION)
TABLE 11. GLOBAL NANOMEDICINE MARKET FOR CARDIOVASCULAR DISEASES INDICATION, BY REGION, 2016-2023 ($MILLION)
TABLE 12. GLOBAL NANOMEDICINE MARKET FOR ORTHOPEDIC DIORDERS INDICATION, BY REGION, 2016-2023 ($MILLION)
TABLE 13. GLOBAL NANOMEDICINE MARKET FOR NEUROLOGICAL DISORDERS INDICATION, BY REGION, 2016-2023 ($MILLION)
TABLE 14. GLOBAL NANOMEDICINE MARKET FOR UROLOGICAL DISEASES INDICATION, BY REGION, 2016-2023 ($MILLION)
TABLE 15. GLOBAL NANOMEDICINE MARKET FOR OPHTHALMOLOGICAL DISEASES INDICATION, BY REGION, 2016-2023 ($MILLION)
TABLE 16. GLOBAL NANOMEDICINE MARKET FOR IMMUNOLOGICAL DISEASES INDICATION, BY REGION, 2016-2023 ($MILLION)
TABLE 17. GLOBAL NANOMEDICINE MARKET FOR OTHERS INDICATION, BY REGION, 2016-2023 ($MILLION)
TABLE 18. GLOBAL NANOMEDICINE MARKET, BY MODALITY, 2016-2023 ($MILLION)
TABLE 19. GLOBAL NANOMEDICINE MARKET FOR TREATMENT MODALITY, BY REGION, 2016-2023 ($MILLION)
TABLE 20. GLOBAL NANOMEDICINE MARKET FOR DIAGNOSTICS MODALITY, BY REGION, 2016-2023 ($MILLION)
TABLE 21. NANOMEDICINE MARKET, BY REGION, 2016-2023 ($MILLION)
TABLE 22. NORTH AMERICA NANOMEDICINE MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 23. NORTH AMERICA NANOMEDICINE MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 24. NORTH AMERICA NANOMEDICINE MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 25. NORTH AMERICA NANOMEDICINE MARKET, BY MODALITY, 2016-2023 ($MILLION)
TABLE 26. EUROPE NANOMEDICINE MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 27. EUROPE NANOMEDICINE MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 28. EUROPE NANOMEDICINE MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 29. EUROPE NANOMEDICINE MARKET, BY MODALITY, 2016-2023 ($MILLION)
TABLE 30. ASIA-PACIFIC NANOMEDICINE MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 31. ASIA-PACIFIC NANOMEDICINE MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 32. ASIA-PACIFIC NANOMEDICINE MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 33. ASIA-PACIFIC NANOMEDICINE MARKET, BY MODALITY, 2016-2023 ($MILLION)
TABLE 34. LAMEA NANOMEDICINE MARKET, BY COUNTRY, 2016-2023 ($MILLION)
TABLE 35. LAMEA NANOMEDICINE MARKET, BY APPLICATION, 2016-2023 ($MILLION)
TABLE 36. LAMEA NANOMEDICINE MARKET, BY INDICATION, 2016-2023 ($MILLION)
TABLE 37. LAMEA NANOMEDICINE MARKET, BY MODALITY, 2016-2023 ($MILLION)
TABLE 38. ABBOTT: COMPANY SNAPSHOT
TABLE 39. ABBOTT: OPERATING SEGMENTS
TABLE 40. COMBIMATRIX: COMPANY SNAPSHOT
TABLE 41. COMBIMATRIX: OPERATING SEGMENTS
TABLE 42. GE: COMPANY SNAPSHOT
TABLE 43. GE: OPERATING SEGMENTS
TABLE 44. SIGMA: COMPANY SNAPSHOT
TABLE 45. SIGMA: OPERATING SEGMENTS
TABLE 46. J&J: COMPANY SNAPSHOT
TABLE 47. J&J: OPERATING SEGMENTS
TABLE 48. MALLINCKRODT: COMPANY SNAPSHOT
TABLE 49. MALLINCKRODT: OPERATING SEGMENTS
TABLE 50. MERCK: COMPANY SNAPSHOT
TABLE 51. MERCK: OPERATING SEGMENTS
TABLE 52. LUMINEX: COMPANY SNAPSHOT
TABLE 53. LUMINEX: OPERATING SEGMENTS
TABLE 54. PFIZER: COMPANY SNAPSHOT
TABLE 55. PFIZER: OPERATING SEGMENTS
TABLE 56. TEVA: COMPANY SNAPSHOT
TABLE 57. TEVA: OPERATING SEGMENTS

LIST OF FIGURE

FIGURE 1. SNAPSHOT GLOBAL NANOMEDICINE MARKET, 2016-2023
FIGURE 2. TOP INVESTMENT POCKETS IN GLOBAL NANOMEDICINE MARKET
FIGURE 3. TOP WINNING STRATEGIES: PERCENTAGE DISTRIBUTION (2014-2016)
FIGURE 4. TOTAL NUMBER OF STRATEGIES: GLOBAL DISPOSABLE MEDICAL SENSORS MARKET
FIGURE 5. TOP WINNING STRATEGIES: NATURE AND COMPANY
FIGURE 6. BARGAINING POWER OF BUYERS
FIGURE 7. BARGAINING POWER OF SUPPLIERS
FIGURE 8. THREAT OF NEW ENTRANTS
FIGURE 9. THREAT OF SUBSTITUTION
FIGURE 10. COMPETITIVE RIVALRY
FIGURE 11. MARKET SHARE ANALYSIS: NANOMEDICINE MARKET, 2016
FIGURE 12. RESTRAINTS AND DRIVERS: GLOBAL NANOMEDICINE MARKET
FIGURE 13. GLOBAL NANOMEDICINE MARKET, BY APPLICATION
FIGURE 14. NANOMEDICINE MARKET, BY INDICATION
FIGURE 15. NANOMEDICINE MARKET, BY REGION
FIGURE 16. NORTH AMERICA NANOMEDICINE MARKET, 2016-2023
FIGURE 17. U.S. NANOMEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 18. MEXICO NANOMEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 19. CANADA NANOMEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 20. GERMANY NANOMEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 21. UK NANOMEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 22. FRANCE NANOMEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 23. ITALY NANOMEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 24. SPAIN NANOMEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 25. REST OF EUROPE NANOMEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 26. INDIA NANOMEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 27. CHINA NANOMEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 28. JAPAN NANOMEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 29. AUSTRALIA NANOMEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 30. REST OF ASIA-PACIFIC NANOMEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 31. BRAZIL NANOMEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 32. SOUTH AFRICA NANOMEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 33. SOUTH ARABIA NANOMEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 34. ARGENTINA NANOMEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 35. REST OF LAMEA NANOMEDICINE MARKET, 2016-2023 ($MILLION)
FIGURE 36. ABBOTT: NET SALES, 2014-2017 ($MILLION)
FIGURE 37. ABBOTT: REVENUE BY SEGMENT, 2016 (%)
FIGURE 38. ABBOTT: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 39. COMBIMATRIX: NET SALES, 2014-2017 ($MILLION)
FIGURE 40. COMBIMATRIX: REVENUE BY SEGMENT, 2016 (%)
FIGURE 41. COMBIMATRIX: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 42. GE: NET SALES, 2014-2017 ($MILLION)
FIGURE 43. GE: REVENUE BY SEGMENT, 2016 (%)
FIGURE 44. GE: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 45. J&J: NET SALES, 2014-2017 ($MILLION)
FIGURE 46. J&J: REVENUE BY SEGMENT, 2016 (%)
FIGURE 47. J&J: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 48. MALLINCKRODT: NET SALES, 2014-2017 ($MILLION)
FIGURE 49. MALLINCKRODT: REVENUE BY SEGMENT, 2016 (%)
FIGURE 50. MALLINCKRODT: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 51. MERCK: NET SALES, 2014-2017 ($MILLION)
FIGURE 52. MERCK: REVENUE BY SEGMENT, 2016 (%)
FIGURE 53. MERCK: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 54. LUMINEX: NET SALES, 2014-2017 ($MILLION)
FIGURE 55. LUMINEX: REVENUE BY SEGMENT, 2016 (%)
FIGURE 56. LUMINEX: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 57. PFIZER: NET SALES, 2014-2017 ($MILLION)
FIGURE 58. PFIZER: REVENUE BY SEGMENT, 2016 (%)
FIGURE 59. PFIZER: REVENUE BY GEOGRAPHY, 2016 (%)
FIGURE 60. TEVA: NET SALES, 2014-2017 ($MILLION)
FIGURE 61. TEVA: REVENUE BY SEGMENT, 2016 (%)
FIGURE 62. TEVA: REVENUE BY GEOGRAPHY, 2016 (%)